Effectiveness Of Individualized Homoeopathic Medicine In The Treatment Of Female Pattern Hair Loss(FPHL): An Open Observational Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 41
- 试验地点
- 1
- 主要终点
- The general well-being & reduction of hair fall of the patient will be recorded on the
研究概览
简要总结
Female pattern hair loss (FPHL) has replaced androgenetic alopecia (AGA) in women as the accepted nomenclature due to the lack of clarity surrounding the relationship between androgens and this disorder.A Prospective, open label, non-randomized, non-controlled, single-arm clinical study. The whole study will take approximately around 12 months. Detailed and thorough case taking of each and every Female patient of reproductive age group (15 - 49 years) suffering from Patients with FPHL shall be done in accordance with the direction laid down by Dr. C. F. S. Hahnemann in the Organon of Medicine from §83 to §104. Indicated Homoeopathic medicines in Centesimal or Fifty Millesimal potencies will be given as per the requirement and direction of Hahnemann, from NIH dispensary as selected appropriate to the case or condition according to the symptom totality based on §153 i.e. Striking, Singular, Uncommon and Peculiar (Characteristics) Signs and Symptoms, dose and repetition will be according to the case.The outcomes will be assessed at baseline & after 3 months and at 6 months if possible. Each enrolled case will be followed up every month, examination will be done at the baseline, at 3 months and at end of the study to assess decrease in hair fall. The general well-being and reduction of hair fall of the patient will be recorded on the basis of score obtained by Ludwig’s criteria and dermatology life quality index (DLQI) questionnaires.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 15.00 Year(s) 至 49.00 Year(s)（—）
- 性别
- Female
入选标准
- •1.Female patient of reproductive age group (15 TO 49 years) suffering from Patients with FPHL.
- •2.Patients of all religions and of varied socioeconomic status.
- •3.Patients giving written consent to participate in the study.
- •4.Patients with FPHL with or without comorbidity.
- •5.Must know/understand either Bengali or Hindi or English.
- •Providing written informed consents.
排除标准
- •Female patients below the age of 15years & above the age of 49 years.
- •Cases suffering from uncontrolled systemic illness or life-threatening infections.
- •Unwilling to take part and not giving consent to join the study.
- •Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure.
- •Pregnant women and lactating mothers
- •Substance abuse and/or dependence.
- •Self-reported immune-compromised state, and
- •Undergoing homoeopathic treatment for any chronic disease within last 6 months.
结局指标
主要结局
The general well-being & reduction of hair fall of the patient will be recorded on the
时间窗: The outcomes will be assessed at baseline & after 3 months & at 6 months.
Each enrolled case will be followed up every month, examination will be done at the
时间窗: The outcomes will be assessed at baseline & after 3 months & at 6 months.
baseline, at 3 months & at end of the study to assess decrease in hair fall.
时间窗: The outcomes will be assessed at baseline & after 3 months & at 6 months.
basis of score obtained by dermatology life quality index (DLQI)
时间窗: The outcomes will be assessed at baseline & after 3 months & at 6 months.
questionnaires.
时间窗: The outcomes will be assessed at baseline & after 3 months & at 6 months.
次要结局
- The general well-being & reduction of hair fall of the patient will be recorded on the(basis of score obtained by ludwigs criteria.)